UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey

Transplant infectious disease, 2008-04, Vol.10 (2), p.106-109

2008

Volltextzugriff (PDF)

JAK2 46 1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia

Leukemia, 2010-10, Vol.24 (10), p.1809-1813

2010

Volltextzugriff (PDF)

P115 Nilotinib (AMN 107) plus involved field irradiation therapy in extramedullary lymphoid and medullary myeloid blast crisis of chronic myeloid leukemia

Blood reviews, 2007, Vol.21, p.S123-S123

2007

Volltextzugriff (PDF)

P011 Myeloablative stem cell transplantation for imatinib resistant advanced phase CML: chronic GVHD indicates better disease control

Blood reviews, 2007, Vol.21, p.S89-S90

2007

Volltextzugriff (PDF)

O21 A retrospective single-center experience with bortezomib-based therapy of relapsed and/or refractory multiple myeloma: survival results of our first 104 consecutive patients

Blood reviews, 2007, Vol.21, p.S73-S74

2007

Volltextzugriff (PDF)

P119 Clinical characteristics of JAK2 V617F positive myeloproliferative diseases

Blood reviews, 2007, Vol.21, p.S124-S124

2007

Volltextzugriff (PDF)

P013 Complete resolution of Behcet's disease after HLA-mismatched allogeneic peripheral haematopoietic stem cell transplantation for myelodysplastic syndrome case report

Blood reviews, 2007, Vol.21, p.S90-S90

2007

Volltextzugriff (PDF)

O37 BCR-ABL kinase domain mutations and clonal evolution as major causes of resistance to targeted therapy in chronic myelogenous leukemia

Blood reviews, 2007, Vol.21, p.S78-S79

2007

Volltextzugriff (PDF)

P077 NPM1 and FLT3 mutations in acute myeloid leukemia

Blood reviews, 2007, Vol.21, p.S110-S111

2007

Volltextzugriff (PDF)

Monocytic aleukemic leukemia cutis

Journal of the European Academy of Dermatology and Venereology, 1999-07, Vol.13 (1), p.54-58

1999

Volltextzugriff (PDF)

The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia

Haematologica (Roma), 2011-11, Vol.96 (11), p.1613-1618

2011

Volltextzugriff (PDF)

Ten-year remission of psoriasis after allogeneic but not autologous bone marrow transplantation

Dermatology (Basel), 2006-01, Vol.212 (1), p.88-89

2006

Volltextzugriff (PDF)

Monocytic aleukemic leukemia cutis

Journal of the European Academy of Dermatology and Venereology, 1999-07, Vol.13 (1), p.54-58

1999

Volltextzugriff (PDF)

Determination of beta-emitting impurities in radioactive certified reference materials to be used at nuclear facilities

Acta physica hungarica, 1986-03, Vol.59 (1-2), p.103-106

1986

Volltextzugriff (PDF)

Monocytic aleukemic leukemia cutis

Orvosi hetilap, 1998-06, Vol.139 (26), p.1585

1998

Volltextzugriff (PDF)

Monocytic aleukemic leukemia cutis

Journal of the European Academy of Dermatology and Venereology, 1999, Vol.13 (1), p.54-58

1999

Volltextzugriff (PDF)

Acalabrutinib and its use in the treatment of chronic lymphocytic leukemia

Future oncology (London, England), 2022-03, Vol.18 (7), p.755-769

2022

Volltextzugriff (PDF)

Is iron deficiency anemia always microcytic?

Polskie archiwum medycyny wewne̦trznej, 2021-02, Vol.131 (2), p.199-201

2021

Volltextzugriff (PDF)

Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients

Acta haematologica, 2012-01, Vol.127 (1), p.34-42

2012

Volltextzugriff (PDF)

HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for Chronic Myeloproliferative Disease

Cancer epidemiology, biomarkers & prevention, 2009-03, Vol.18 (3), p.929-934

2009

Volltextzugriff (PDF)

Hemochromatosis and Hemojuvelin G320V Homozygosity in a Hungarian Woman

Acta haematologica, 2010-01, Vol.123 (3), p.191-193

2010

Volltextzugriff (PDF)

Clinical Characteristics of JAK2 V617F Mutation Positive Acute Myeloid Leukemia

Blood, 2006-11, Vol.108 (11), p.4508-4508

2006

Volltextzugriff (PDF)

HFE C282Y Mutation as a Genetic Modifier Influeincing Disease Susceptibility for Chronic Myeloproliferative Disease

Cancer epidemiology, biomarkers & prevention, 2009, Vol.18 (3), p.929-934

2009

Volltextzugriff (PDF)

Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy

Heart failure reviews, 2008-06, Vol.13 (2), p.227-244

2008

Volltextzugriff (PDF)

HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for JAK2 V617F Positive Chronic Myeloproliferative Disease

Blood, 2006-11, Vol.108 (11), p.4904-4904

2006

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(14)
Science & Technology
(12)
Life Sciences & Biomedicine
(11)
Adult
(10)
Female
(10)
Hematology, Oncology And Palliative Medicine
(7)
Male
(7)
Middle Aged
(7)
Adolescent
(5)
Treatment Outcome
(5)
Aged
(4)
Hematology
(4)
Janus Kinase 2 - Genetics
(4)
Acute Monoblastic Leukemia
(3)
Biological And Medical Sciences
(3)
Child
(3)
Hematologic And Hematopoietic Diseases
(3)
Hungary
(3)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(3)
Medical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey

JAK2 46 1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia

P115 Nilotinib (AMN 107) plus involved field irradiation therapy in extramedullary lymphoid and medullary myeloid blast crisis of chronic myeloid leukemia

P011 Myeloablative stem cell transplantation for imatinib resistant advanced phase CML: chronic GVHD indicates better disease control

O21 A retrospective single-center experience with bortezomib-based therapy of relapsed and/or refractory multiple myeloma: survival results of our first 104 consecutive patients

P119 Clinical characteristics of JAK2 V617F positive myeloproliferative diseases

P013 Complete resolution of Behcet's disease after HLA-mismatched allogeneic peripheral haematopoietic stem cell transplantation for myelodysplastic syndrome case report

O37 BCR-ABL kinase domain mutations and clonal evolution as major causes of resistance to targeted therapy in chronic myelogenous leukemia

P077 NPM1 and FLT3 mutations in acute myeloid leukemia

Monocytic aleukemic leukemia cutis

The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia

Ten-year remission of psoriasis after allogeneic but not autologous bone marrow transplantation

Monocytic aleukemic leukemia cutis

Determination of beta-emitting impurities in radioactive certified reference materials to be used at nuclear facilities

Monocytic aleukemic leukemia cutis

Monocytic aleukemic leukemia cutis

Acalabrutinib and its use in the treatment of chronic lymphocytic leukemia

Is iron deficiency anemia always microcytic?

Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients

HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for Chronic Myeloproliferative Disease

Hemochromatosis and Hemojuvelin G320V Homozygosity in a Hungarian Woman

Clinical Characteristics of JAK2 V617F Mutation Positive Acute Myeloid Leukemia

HFE C282Y Mutation as a Genetic Modifier Influeincing Disease Susceptibility for Chronic Myeloproliferative Disease

Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy

HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for JAK2 V617F Positive Chronic Myeloproliferative Disease

Suchergebnisse filtern